产品中心Cell Resources
联系我们CONTACT US
- 400-999-210024小时服务热线
产品概述
产品简介
HSC-T6细胞专用培养基由普诺赛技术团队精心优化,经过长期测试,本产品可保持HSC-T6细胞最佳的生长状态。本产品中已包含HSC-T6细胞生长所需的各种成分,无需添加任何成分,可直接用于HSC-T6细胞的体外培养。本产品仅供进一步科研使用,不得用于诊断、治疗、临床、家庭及其它用途。
产品说明
产品形态 | 液体 |
产品浓度 | 1× |
产品规格 | 125mL×4 |
培养基成分 | DMEM(PM150210)+10% FBS(164210-50)+1% P/S(PB180120) |
细菌检测 | 阴性 |
真菌检测 | 阴性 |
支原体检测 | 阴性 |
细胞生长实验 | 细胞生长良好,形态正常 |
内毒素含量(EU/mL) | ≤3 |
储存条件 | 2-8℃,避光储存 |
运输条件 | 冰袋冷藏运输 |
有效期 | 6个月 |
注意事项
参考文献
-
Preparation of pectin-coated and chitosan-coated phenylethanoside liposomes: Studies on characterization, stability, digestion and release behavior (2024-01-15)
作者:Lingling Su:1.College of Food Science & Biology, Hebei University of Science & Technology, Shijiazhuang 050000, China. ; Dandan Zhao:1.College of Food Science & Biology, Hebei University of Science & Technology, Shijiazhuang 050000, China. Electronic address: zdd2016@hebust.edu.cn. ; Qiong Huang:1.Xinjiang Cong Rong Tang Biotechnology Co., LTD, 848000, China. ; Xia Zhao:1.College of Food Science & Biology, Hebei University of Science & Technology, Shijiazhuang 050000, China. ; Qijia Chen:1.College of Food Science & Biology, Hebei University of Science & Technology, Shijiazhuang 050000, China. ; Huan Rao:1.College of Food Science & Biology, Hebei University of Science & Technology, Shijiazhuang 050000, China. ; Limin Guo:1.Institute of Agro-Production Storage and Processing, Xinjiang Academy of Agricultural Sciences, Ürümqi 830091, China. Electronic address: 496369147@qq.com. ; Jianxiong Hao:1.College of Food Science & Biology, Hebei University of Science & Technology, Shijiazhua
期刊:Preparation of pectin-coated and chitosan-coated phenylethanoside liposomes: Studies on characterization, stability, digestion and release behavior
DOI:10.1016/j.ijbiomac.2024.129442
影响因子 :8.2
引用产品: HSC-T6 细胞 , NR8383 [AgC11x3A; NR8383.1] 细胞 , HSC-T6细胞专用培养基 , NR8383细胞专用培养基
-
MANF brakes TLR4 signaling by competitively binding S100A8 with S100A9 to regulate macrophage phenotypes in hepatic fibrosis (2023-08-01)
作者:Chao Hou:1.School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China. ; 2.Biopharmaceutical Research Institute, Anhui Medical University, Hefei 230032, China. ; Dong Wang:1.School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China. ; 2.Biopharmaceutical Research Institute, Anhui Medical University, Hefei 230032, China. ; Mingxia Zhao:1.School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China. ; 2.Biopharmaceutical Research Institute, Anhui Medical University, Hefei 230032, China. ; Petek Ballar:1.Department of Biochemistry, Faculty of Pharmacy, Ege University, Izmir 35100, Turkey. ; Xinru Zhang:1.School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China. ; 2.Biopharmaceutical Research Institute, Anhui Medical University, Hefei 230032, China. ; Qiong Mei:1.School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China. ; 2.Biopharmaceutical Research Institute, Anhui Medical Uni
期刊:MANF brakes TLR4 signaling by competitively binding S100A8 with S100A9 to regulate macrophage phenotypes in hepatic fibrosis
DOI:10.1016/j.apsb.2023.07.027
影响因子 :14.5
引用产品: HSC-T6细胞专用培养基
-
Blocking P2X4 purinergic receptor attenuates alcohol-related liver fibrosis by inhibiting hepatic stellate cell activation through PI3K/AKT signaling pathway (2022-10-17)
作者:Zi Xuan Li:1.Institute for Liver Diseases of Anhui Medical University, Hefei, China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei, China; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China. ; Xiao Dong Sheng:1.Institute for Liver Diseases of Anhui Medical University, Hefei, China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei, China; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China. ; Yu Lian Wang:1.Institute for Liver Diseases of Anhui Medical University, Hefei, China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei, China; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, Sc
期刊:Blocking P2X4 purinergic receptor attenuates alcohol-related liver fibrosis by inhibiting hepatic stellate cell activation through PI3K/AKT signaling pathway
DOI:10.1016/j.intimp.2022.109326
影响因子 :5.7
引用产品: HSC-T6细胞专用培养基
FAQs
Q:{{item.question}}
A:
产品资料
识别码示意图